English
ThisiscontentfromClinicalKey
Sign up for your free ClinicalKey trial today! Your first step in getting the right answers when you need them. ClinicalKey is a clinical knowledge solution designed to help healthcare professionals and students find the right answers by providing in-depth, evidence-based knowledge – all from one resource.
Evaluate all obese patients for obesity-related comorbidities, and counsel them regarding their increased risk of cardiovascular disease
First line therapy for all patients with BMI of 25 kg/m² or higher is lifestyle modification consisting of reduced calorie diet in conjunction with physical activity and behavioral therapy to achieve weight loss r2
Pharmacotherapy is indicated as an adjunct to lifestyle therapy for patients with BMI of 30 kg/m² or more, for those with BMI of 27 kg/m² or more plus obesity-related comorbidity,r6 and for those in whom lifestyle modification alone fails to achieve weight loss goals r4
Consider bariatric surgery for patients with BMI of 40 kg/m² or more, for those with BMI of 35 kg/m² or more plus any obesity-related comorbidity,r6 or when sufficient weight loss has not been achieved by other methods r4
Comprehensive lifestyle intervention r19